Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study.
Cynthia ReichlingJulien TaiebValentin DerangereQuentin KlopfensteinKarine Le MalicotJean-Marc GornetHakim BecheurFrancis FeinOana CojocarasuMarie Christine KaminskyJean Paul LagasseDominique LuetSuzanne NguyenPierre-Luc EtienneMohamed GasmiAndre VanoliHervé PerrierPierre-Laurent PuigJean-François EmileCome LepageFrançois GhiringhelliPublished in: Gut (2019)
These findings suggest that artificial intelligence can potentially improve patient care by assisting pathologists in better defining stage III colon cancer patients' prognosis.